Sevil Sadri

6PUBLICATIONS
72CO-AUTHORS
Sport and exercise nutritionCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Probable sarcopenia and bone health in transfusion-dependent beta thalassemia patients.

|Jun 25, 2026
Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study.

|Jun 12, 2026
Time-Dependent Prognostic Value of the mEASIX Score in Patients with Myelodysplastic Syndromes.

|Oct 16, 2024
Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia.

Nazif Yalcin, Sevil Sadri, Ayşegül Ertınmaz Özkan

|Jun 22, 2022
Do neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience.

Sevil Sadri, Gunes Cavusoglu, Burcu Tunay

|Sep 15, 2021
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden

Pageof 1

Frequent Collaborators

2 joint publications

Rafiye Çiftçiler

2 joint publications

Vildan Gürsoy

2 joint publications

Fahir Özkalemkaş

2 joint publications

Ünal Ataş